Background. A large number of clinical and laboratory markers have been appraised to
predict prognosis in patients with stable angina, but uncertainty remains regarding which …

The role of percutaneous coronary intervention (PCI) in patients with ST elevation
myocardial infarction (STEMI) is clear (European Society of Cardiology STEMI Guideline …

Background—The Clinical Outcomes Utilizing Revascularization and Aggressive Drug
Evaluation (COURAGE) trial enrolled patients from 3 distinct healthcare systems (HCSs) in …

Background Patients with stable coronary heart disease (CHD) have widely varying
prognoses and treatment options. Validated models for risk stratification of patients with …

Importance Biomarkers may improve prediction of cardiovascular events for patients with
stable coronary artery disease (CAD), but their importance in addition to clinical tests of …

The long‐term progression of coronary artery disease as defined by the natural disease
course years after a myocardial infarction (MI) is an important but poorly studied area of …

Background: Percutaneous coronary intervention (PCI) is a therapy to reduce angina and
improve quality of life in patients with stable ischemic heart disease. However, it is unclear …

Coronary artery disease (CAD) is the leading cause of death in the United States, but
prevention and intervention efforts are lowering mortality. This progress is being undercut by …

Stable angina affects a significant number of coronary artery disease patients, impairing
their quality of life and worsening their prognosis. It manifests even despite a history of …

Background Despite major advances in prevention and treatment, coronary artery disease
(CAD) remains the leading cause of death worldwide. Whereas many sources of data are …